1. Howlader, N., Noone, A., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S., Kosary, C., Yu, M., Ruhl, J., Tatalovich, Z., Cho, H., Mariotto, A., Lewis, D., Chen, H., Feuer, E. (1975–2010). SEER Cancer Statistics Review, National Cancer Institute. Available from URL: http://seer.cancer.gov/csr/1975_2010/ . Accessed 2 June 2013.
2. Surveillance, Epidemiology, and End Results (SEER). SEER Stat Fact Sheets: Prostate. Available from URL: http://seer.cancer.gov/statfacts/html/prost.html . Accessed May 2013.
3. Miller, A. B. (2012). New data on prostate-cancer mortality after PSA screening. New England Journal of Medicine, 366, 1047–1048.
4. Stanford, J., Stephenson, R., Coyle, L., Cerhan, J., Correa, R., Eley, J., et al. (1999). Survival. Prostate cancer trends, 1973–1995. Bethesda: SEER Program, National Cancer Institute.
5. Suwa, T., Nyska, A., Haseman, J. K., Mahler, J. F., & Maronpot, R. R. (2002). Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs. Toxicologic Pathology, 30, 228–234.